Skip to main content
SpringerLink
Log in

The Role of Treatment Motivation Subsystems in the Overall Structure of Compliance in Patients Undergoing Psychopharmacotherapy

  • Published:
Neuroscience and Behavioral Physiology Aims and scope Submit manuscript

Objective. To identify interactions in the structure of treatment motivation and compliance in patients in a psychiatric clinic. Materials and methods. A questionnaire and compliance scales were used to assess treatment motivation in 104 patients in the Department of Integrative Pharmaco- and Psychotherapy. These included 67 patients with schizophrenia and schizoaffective spectrum disorders, 15 with affective disorders, 13 with personality disorders and neurotic disorders, and nine with organic lesions. Results and conclusions. The key role in forming the overall level of treatment compliance is played by the motivation mechanism based on subjective experience of suffering from the disorder. Occurrence of amotivation syndrome has disastrous effects on the formation of compliance. Passive agreement by the patient to accept treatment leads to a degradation in the treatment alliance, which is worsened by cognitive deficit in patients and reduced insight into the condition. Predominance of external motivation to receive treatment, determined by the pressure of the patient’s immediate environment, also had adverse impact on the compliance subsystem linked with the surroundings. Pressure from relatives was often not transformed into adequate social support. Extremely low levels of internal motivation based on an understanding of the nature of the disorder, led to decreases in compliance associated with attitudes to treatment with medication.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. M. Sajatovic, M. Davies, and D. Hrouda, “Enhancement of treatment adherence among patients with bipolar disorder,” Psychiatr. Serv., 55, No. 3, 264–269 (2004), doi: https://doi.org/10.1176/appi.ps.55.3.264.

    Article  PubMed  Google Scholar 

  2. C. Dolder, J. Lacro, S. Leckband, and D. Jeste, “Interventions to improve antipsychotic medication adherence: review of recent literature,” J. Clin. Psychopharmacol., 23, No. 4, 389–399 (2003), doi: https://doi.org/10.1097/01.jcp.0000085413.08426.41.

    Article  PubMed  Google Scholar 

  3. A. Zygmunt, M. Olfson, C. Boyer, and D. Mechanic, “Interventions to improve medication adherence in schizophrenia,” Am. J. Psyhiatry, 159, No. 10, 1653–1664 (2002), doi: https://doi.org/10.1176/appi.ajp.159.10.1653.

    Article  Google Scholar 

  4. D. Barch, “The relationships among cognition, motivation, and emotion in schizophrenia: how much and how little we know,” Schizophr. Bull., 31, No. 4, 875–881 (2005), doi: https://doi.org/10.1093/schbul/sbi040.

    Article  PubMed  Google Scholar 

  5. D. Velligan, R. Kern, and J. Gold, “Cognitive rehabilitation for schizophrenia and the putative role of motivation and expectancies,” Schizophr. Bull., 32, No. 3, 474–485 (2005), doi: https://doi.org/10.1093/schbul/sbj071.

    Article  Google Scholar 

  6. D. Gard, M. Fisher, C. Garrett, et al., “Motivation and its relationship to neurocognition, social cognition, and functional outcome in schizophrenia,” Schizophr. Res., 115, No. 1, 74–81 (2009), doi: https://doi.org/10.1016/j.schres.2009.08.015.

    Article  PubMed  PubMed Central  Google Scholar 

  7. E. Nakagami, B. Xie, M. Hoe, and J. Brekke, “Intrinsic motivation, neurocognition and psychosocial functioning in schizophrenia: Testing mediator and moderator effects,” Schizophr. Res., 105, No. 1–3, 95–104 (2008), doi: https://doi.org/10.1016/j.schres.2008.06.015.

    Article  PubMed  Google Scholar 

  8. V. D. Wied, Structure and Dynamics of the Process of Psychotherapy in Complex with Restorative Treatment of Low-Grade Schizophrenia: Auth. Abstr. Doct. Thesis in Med. Sci., Leningrad (1991).

  9. G. V. Logvinovich, “Clinical characteristics of patients with episodes-progressive schizophrenia with the introverted type of adaptation,” in: Current Challenges in Psychiatry, Tomsk (1985).

  10. F. Tremeau, J. Goldman, D. Antonius, and D. Javitt, “In-patients with schizophrenia report impaired situational motivation but intact global and social motivation,” Psychiatry Res., 210, No. 1, 43–49 (2013), doi: https://doi.org/10.1016/j.psychres.2013.05.031.

    Article  PubMed  Google Scholar 

  11. S. D. Mikhailova, “The challenge of nosophilic behavior in endogenousd patients with affective disorders,” in: Affective Disorders. Diagnosis, Treatment, Rehabilitation, Leningrad (1988), pp. 143–148.

  12. V. N. Kalinkin, “The challenge of neohospitalization in occupational medicine workshops,” in: Current Challenges in Psychiatry, Tomsk (1983).

  13. S. Goldstein and L. Dyche, “Family therapy of the schizophrenic poor,” in: Family Therapy in Schizophrenia, New York, London (1983), pp. 283–307.

  14. J. Choi, K. H. Choi, L. Felice Reddy, and J. M. Fiszdon, “Measuring motivation in schizophrenia: Is a general state of motivation necessary for task-specific motivation?” Schizophr. Res., 153, No. 1–3, 209–213 (2014), doi: https://doi.org/10.1016/j.schres.2014.01.027.

    Article  PubMed  PubMed Central  Google Scholar 

  15. K. Choi, A. Saperstein, and A. Medalia, “The relationship of trait to state motivation: The role of self-competency beliefs,” Schizophr. Res., 139, No. 1–3, 73–77 (2012), doi: https://doi.org/10.1016/j.schres.2012.05.001.

    Article  PubMed  Google Scholar 

  16. W. Miller and G. Rose, “Toward a theory of motivational interviewing,” Am. Psychol., 64, No. 6, 527–537 (2009), doi: https://doi.org/10.1037/a0016830.

    Article  PubMed  PubMed Central  Google Scholar 

  17. N. Rusch and P. Corrigan, “Motivational interviewing to improve insight and treatment adherence in schizophrenia,” Psychiatr. Rehabil. J., 26, No. 1, 23–32 (2002), doi: https://doi.org/10.2975/26.2002.23.32.

    Article  PubMed  Google Scholar 

  18. T. Apodaca and R. Longabaugh, “Mechanisms of change in motivational interviewing: a review and preliminary evaluation of the evidence,” Addiction, 104, No. 5, 705–715 (2009), doi: https://doi.org/10.1111/j.1360-0443.2009.02527.x.

    Article  PubMed  PubMed Central  Google Scholar 

  19. R. Kemp and A. David, “Psychological predictors of insight and compliance in psychotic patients,” Brit. J. Psychiatry, 169, No. 4, 444–450 (1996), doi: https://doi.org/10.1192/bjp.169.4.444.

    Article  CAS  Google Scholar 

  20. A. Swanson, M. Pantalon, and K. Cohen, “Motivational interviewing and treatment adherence among psychiatric and dually diagnosed patients,” J. Nerv. Ment. Dis., 187, No. 10, 630–635 (1999), doi: https://doi.org/10.1097/00005053-199910000-00007.

    Article  CAS  PubMed  Google Scholar 

  21. F. Chanut, T. G. Brown, and M. Donguier, “Motivational interviewing and clinical psychiatry,” Can. J. Psychiatry, 50, No. 11, 715–72 (2005).

    Article  PubMed  Google Scholar 

  22. B. Lundahl, C. Kunz, C. Brownell, et al., “A meta-analysis of motivational interviewing: twenty-five years of empirical studies,” Res. Soc. Work Pract., 20, No. 2, 137–160 (2010), doi: https://doi.org/10.1177/1049731509347850.

    Article  Google Scholar 

  23. J. C. Ferron, “Psychological mechanisms to treatment adherence among people with severe mental illness: validating treatment motivation and working alliance measures,” Dissert. Abstr. Int. A, Human. Soc. Sci., 68, No. 11, 486 (2008).

  24. N. B. Lutova and M. Yu. Sorokin, “Characteristics of the treatment motivation of psychiatric clinic patients,” Vestn. Psikhoter., 51, 68–79 (2014).

    Google Scholar 

  25. N. B. Lutova, N. G. Neznanov, and V. D. Wied, “Compliance in psychiatry and means of assessing it,” Psikhoter. Psikhofarmakoter., No. 1, 8–1 (2008).

  26. N. Lutova, N. Neznanov, and V. Wied, “The medication compliance in psychiatry and method of its assessment,” in: Yearbook of International Psychiatry and Behavioral Neurosciences, N. Barton (ed.), Nova Science Publ. Inc., New York (2009), pp. 399–408.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Bekhterev St. Petersburg Research Psychoneurology Institute, St. Petersburg, Russia

    M. Yu. Sorokin, N. B. Lutova & V. D. Wied

Authors
  1. M. Yu. Sorokin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N. B. Lutova
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. V. D. Wied
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Yu. Sorokin.

Additional information

Translated from Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova, Vol. 116, No. 4, pp. 32–36, April, 2016.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sorokin, M.Y., Lutova, N.B. & Wied, V.D. The Role of Treatment Motivation Subsystems in the Overall Structure of Compliance in Patients Undergoing Psychopharmacotherapy. Neurosci Behav Physi 47, 890–894 (2017). https://doi.org/10.1007/s11055-017-0486-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11055-017-0486-z

Keywords

Search

Navigation